Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,403 | 197,292 | 43,374 | 42,740 | 37,296 |
| Marketable Securities | 406,407 | 315,586 | 249,825 | 252,807 | 254,496 |
| Receivables | 51,187 | 48,814 | 46,084 | 46,644 | 46,666 |
| Inventories | 20,537 | 20,562 | 19,227 | 20,292 | 20,986 |
| TOTAL | $570,378 | $593,798 | $369,840 | $371,447 | $367,606 |
| Non-Current Assets | |||||
| PPE Net | 54,975 | 55,174 | 54,093 | 51,771 | 52,224 |
| Other Non-Current Assets | 32,192 | 29,127 | 11,982 | 13,319 | 14,492 |
| TOTAL | $87,167 | $84,301 | $66,075 | $65,090 | $66,716 |
| Total Assets | $657,545 | $678,099 | $435,915 | $436,537 | $434,322 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,854 | 3,034 | 2,876 | 2,889 | 3,017 |
| Accounts payable and accrued liabilities | 9,908 | 11,605 | 6,704 | 4,658 | 6,570 |
| Accrued Expenses | 20,918 | 19,920 | 18,449 | 10,333 | 13,978 |
| TOTAL | $55,202 | $58,238 | $50,632 | $44,630 | $42,673 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,941 | 2,238 | 3,134 | 3,870 | 4,508 |
| Deferred Revenues | 2,914 | 4,355 | 7,473 | 10,302 | 5,565 |
| Other Non-Current Liabilities | 255,484 | 255,769 | 6,049 | 85,830 | 86,098 |
| TOTAL | $268,003 | $268,737 | $9,183 | $89,700 | $90,606 |
| Total Liabilities | $323,205 | $326,975 | $59,815 | $134,330 | $133,279 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,515,149 | 1,509,653 | 1,505,268 | 1,495,018 | 1,425,811 |
| Common Shares | 94 | 189 | 47 | 45 | 45 |
| Retained earnings | -527,729 | -506,008 | -476,743 | -459,179 | -454,993 |
| Other shareholders' equity | 2,403 | -904 | -1,676 | -2,978 | -3,044 |
| TOTAL | $334,340 | $351,124 | $376,100 | $302,207 | $301,043 |
| Total Liabilities And Equity | $657,545 | $678,099 | $435,915 | $436,537 | $434,322 |